| Not Yet Recruiting | Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD) NCT07102043 | University of Alabama at Birmingham | — |
| Recruiting | Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis NCT06995651 | University of Pennsylvania | Phase 1 |
| Recruiting | Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) NCT06837181 | Jaeb Center for Health Research | — |
| Recruiting | CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis NCT06642610 | Indiana University | N/A |
| Recruiting | Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis NCT06560463 | Medical College of Wisconsin | — |
| Completed | Investigating the Relationship Between Glycemia and Sleep in Adults With Cystic Fibrosis-Related Diabetes NCT06700889 | Massachusetts General Hospital | — |
| Recruiting | Bionic Pancreas in CFRD NCT06449677 | Jaeb Center for Health Research | Phase 3 |
| Active Not Recruiting | SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes NCT06149793 | University of Minnesota | Phase 2 / Phase 3 |
| Completed | Semaglutide in CFRD NCT05788965 | University of Minnesota | Phase 2 / Phase 3 |
| Recruiting | The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Rel NCT05723445 | Rhode Island Hospital | N/A |
| Completed | Alternate Measures of Glucose During OGTT Testing for CFRD NCT05568134 | Children's Hospital of Philadelphia | — |
| Recruiting | FEED-Cystic Fibrosis (FEED-CF) NCT05766774 | Emory University | N/A |
| Active Not Recruiting | Closed-loop for People Living With Cystic Fibrosis Related Diabetes NCT05562492 | University of Cambridge | N/A |
| Active Not Recruiting | Cardiac Structure and Function in Patients with Cystic Fibrosis NCT06084468 | Herlev and Gentofte Hospital | — |
| Recruiting | ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2 NCT05463289 | Johns Hopkins University | N/A |
| Withdrawn | Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liv NCT05229640 | Dartmouth-Hitchcock Medical Center | N/A |
| Recruiting | Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function NCT04530383 | University of Kansas Medical Center | Phase 2 |
| Unknown | Performance and Patient Acceptance of a Commercially Available Beverage as Compared to an Oral Glucose Solutio NCT05377502 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Completed | A Pilot Study of a Low Glycemic Load Diet in Adults With Cystic Fibrosis NCT04519853 | Boston Children's Hospital | N/A |
| Completed | Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabete NCT03258853 | Massachusetts General Hospital | N/A |
| Completed | Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes NCT04533646 | Jagdeesh Ullal | Phase 4 |
| Terminated | Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administra NCT04381429 | University Hospital, Strasbourg, France | Phase 4 |
| Unknown | β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis NCT04379726 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Terminated | Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management NCT03939065 | University of Colorado, Denver | N/A |
| Completed | A Comparison of Clinical Parameters in With and Without Abnormal Glucose Tolerance. NCT04503408 | Hacettepe University | — |
| Completed | EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis NCT03650712 | Katie Larson Ode | N/A |
| Completed | Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis NCT03961516 | University Hospitals Cleveland Medical Center | — |
| Completed | Measurement of Beta Cell Death in Individuals With Cystic Fibrosis NCT03713437 | University of Nebraska | — |
| Terminated | A CFit Study - Acute Exercise NCT03237767 | University of Portsmouth | N/A |
| Terminated | A CFit Study - Baseline NCT03234387 | University of Portsmouth | — |
| Completed | Simplification of CF-related Diabetes Screening at Home NCT03227094 | Institut de Recherches Cliniques de Montreal | N/A |
| Completed | Nutritional Intervention and Glycemic Improvement in Patients With Pre-diabetic Cystic Fibrosis. NCT03205904 | Hospital de Clinicas de Porto Alegre | N/A |
| Completed | The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic Fibrosis NCT02810691 | Institut de Recherches Cliniques de Montreal | N/A |
| Unknown | The Use of Home Oral Glucose Tolerance Test Kit in Screening Cystic Fibrosis Related Diabetes NCT02703155 | Great Ormond Street Hospital for Children NHS Foundation Trust | N/A |
| Completed | Role of Glucagon In Glucose Control in Cystic Fibrosis Related Diabetes NCT02398383 | Yale University | EARLY_Phase 1 |
| Completed | Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF) NCT02039986 | Children's Hospital of Philadelphia | — |
| Completed | Effects of an Exercise Program Among CF Patients With Dysglycemia NCT02127957 | Institut de Recherches Cliniques de Montreal | N/A |
| Completed | Cystic Fibrosis Related Diabetes Screening. NCT02723968 | Hospices Civils de Lyon | N/A |
| Terminated | Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD) NCT00639626 | Nationwide Children's Hospital | Phase 2 / Phase 3 |
| Enrolling By Invitation | Genetic Modifiers of Cystic Fibrosis Related Diabetes NCT01113216 | Johns Hopkins University | — |
| Completed | Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis NCT00763412 | Arbelaez, Ana Maria | N/A |
| Withdrawn | Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diab NCT00287456 | University of Texas Southwestern Medical Center | N/A |
| Completed | Insulin Glargine Vs Standard Insulin Therapy NCT00222521 | University of Minnesota | Phase 3 |
| Completed | The Microvascular Complications Study NCT00222508 | University of Minnesota | — |